Egalet is a fully integrated specialty pharmaceutical company focused on developing effective medicines for patients with acute and chronic pain while helping to protect physicians, families, and communities from the burden of abuse.

Egalet is employing its proprietary Guardian Technology to develop effective medicines with chemical and physical properties to resist common methods of opioid abuse.

Egalet markets treatments for acute and chronic pain that are intended to reduce the likelihood of prescription opioid abuse, including opioids with abuse-deterrent features and non-opioid alternatives.

Egalet is the first to combine injection molding with pharmaceutical production to produce orally delivered pharmaceutical products.